Tomoko Warita 研究室

AI 要約（直近 5 年の研究成果）

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

研究成果（17 件）

• [2025] Effects of Low-Dose Atorvastatin on Hypoxic Response in Statin-Sensitive and Statin-Resistant Cancer Cells
  DOI: https://doi.org/10.1248/bpb.b25-00258
• [2024] Exploration of Novel Metabolic Features Reflecting Statin Sensitivity in Lung Cancer Cells
  DOI: https://doi.org/10.1248/bpb.b24-00346
• [2024] Repurposing of the Cardiovascular Drug Statin for the Treatment of Cancers: Efficacy of Statin–Dipyridamole Combination Treatment in Melanoma Cell Lines
  DOI: https://doi.org/10.3390/biomedicines12030698
• [2023] Comparison of the anticancer effects of various statins on canine oral melanoma cells
  DOI: https://doi.org/10.1111/vco.12946
• [2023] CYP11A1 silencing suppresses HMGCR expression via cholesterol accumulation and sensitizes CRPC cell line DU-145 to atorvastatin
  DOI: https://doi.org/10.1016/j.jphs.2023.08.002
• [2023] HMG-CoA reductase degrader, SR-12813, counteracts statin-induced upregulation of HMG-CoA reductase and augments the anticancer effect of atorvastatin
  DOI: https://doi.org/10.1016/j.bbrc.2023.07.056
• [2023] Housekeeping gene expression variability in differentiating and non-differentiating 3T3-L1 cells
  DOI: https://doi.org/10.1080/21623945.2023.2235081
• [2023] Expression of housekeeping genes varies depending on mevalonate pathway inhibition in cancer cells
  DOI: https://doi.org/10.1016/j.heliyon.2023.e18017
• [2023] The TFDP1 gene coding for DP1, the heterodimeric partner of the transcription factor E2F, is a target of deregulated E2F
  DOI: https://doi.org/10.1016/j.bbrc.2023.04.092
• [2022] Alterations in the omics profiles in mevalonate pathway-inhibited cancer cells
  DOI: https://doi.org/10.1016/j.lfs.2022.121249

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。